idsMED Aesthetics Indonesia Participates in the 3rd ICAP 2025

idsMED Aesthetics Indonesia participated in ICAP 2025, highlighting DOT™-PN through expert sessions by Dr. Hosung Choi and Dr. Inneke Jane. The REJURAN booth attracted strong interest, with doctors actively exploring its scar-treatment and skin-regeneration solutions, supported by interactive surveys and product samples. The event underscored growing confidence in REJURAN’s clinical innovation.

Event News

19 November 2025

Country(s)

idsMED Aesthetics Indonesia reinforced its commitment to advancing the aesthetics industry by participating in the 3rd ICAP 2025, the largest Aesthetic Medicine Congress jointly organised by Indonesia and Korea. Held at Pullman Hotel Central Park, Jakarta, on 15–16 November 2025, the two-day event brought together aesthetic doctors and professionals from across the country.

The first day featured a symposium session led by Dr. Hosung Choi, who presented “Updates on DOT™-PN: Redefining Scar Treatment in Aesthetic Dermatology.” Dr. Choi provided scientific updates on DOT™-PN, the latest polynucleotide innovation from REJURAN, developed to support tissue repair and acne scar treatment. The session drew significant interest as it introduced a new approach to effective scar management with minimal downtime.

High engagement continued at the REJURAN booth, where many doctors visited to learn more about the brand. As a token of appreciation, those who completed the on-site survey received REJURAN Collagen Jelly.

On the second day, scientific discussions continued with a presentation by Dr. Inneke Jane, Sp.DVE, M.Kes, FINSDV, titled “From Inflammation to Regeneration: Achieving Skin Clarity with DOT™-PN.” She outlined the skin’s transition from inflammation to regeneration, emphasising the role of DOT™-PN in supporting healthier, brighter, and more resilient skin. Her session provided practical clinical insights for daily application.

As with the first day, the REJURAN booth drew strong interest, with the team offering REJURAN Serum Samples to doctors who completed the survey, fostering meaningful engagement and interaction.

Throughout the two-day congress, the REJURAN booth remained one of the event’s most visited areas. The consistent interest highlighted the growing recognition of REJURAN for its clinical innovation, evidence-based results, and product quality.

Gallery

Click to enlarge image